Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
July-2018 Volume 18 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2018 Volume 18 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

A novel anti‑proliferative pentapeptide (ILYMP) isolated from Cyclina sinensis protein hydrolysate induces apoptosis of DU‑145 prostate cancer cells

  • Authors:
    • Fangmiao Yu
    • Yaru Zhang
    • Lei Ye
    • Yunping Tang
    • Guofang Ding
    • Xiaojun Zhang
    • Zuisu Yang
  • View Affiliations / Copyright

    Affiliations: School of Food and Pharmacy, Zhejiang Provincial Engineering Technology Research Center of Marine Biomedical Products, Zhejiang Ocean University, Zhoushan, Zhejiang 316022, P.R. China, Aquatic Processing Department, Zhejiang Marine Fisheries Research Institution, Zhoushan, Zhejiang 316021, P.R. China
    Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 771-778
    |
    Published online on: May 14, 2018
       https://doi.org/10.3892/mmr.2018.9019
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Prostate cancer is the main causes of cancer associated mortality in men worldwide, cancer patients often suffer serious side effects when treated with chemotherapy or radiotherapy, therefore novel drugs are in high demand to treat prostate cancer. In the present study, a pentapeptide (Ile‑Leu‑Tyr‑Met‑Pro; ILYMP) with a molecular weight of 635.71 Da was isolated from the protein hydrolysate of Cyclina sinensis via ultrafiltration and chromatographic methods, and subsequently named Cyclina sinensis pentapeptide (CSP). The activity of CSP was first investigated in prostate cancer (PCa) DU‑145 cells. CSP was demonstrated to significantly inhibit DU‑145 cell proliferation at a half‑maximal inhibitory concentration of 11.25 mM at a 72 h time interval. In addition, the results of acridine orange/ethidium bromide double staining, scanning electron microscopy and flow cytometry analyses suggested that CSP inhibited DU‑145 cell proliferation via the induction of apoptosis. Following treatment with CSP, Bcl‑2‑associated X (Bax), cleaved caspase‑3 and cleaved caspase‑9 protein expression levels were enhanced in DU‑145 cells; whereas B‑cell lymphoma 2 expression was suppressed in DU‑145 cells. In conclusion, to the best of the authors' knowledge, this is the first study to investigate the effects of an anti‑proliferative peptide derived from Cyclina sinensis on DU‑145 cells, and the results suggested that CSP may represent a therapeutic nutraceutical agent for the treatment of patients with PCa.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Choo GS, Lee HN, Shin SA, Kim HJ and Jung JY: Anticancer effect of fucoidan on DU-145 prostate cancer cells through inhibition of PI3K/Akt and MAPK pathway expression. Mar Drugs. 14:E1262016. View Article : Google Scholar : PubMed/NCBI

3 

Zhou Y, Ji Z, Yan W, Zhou Z and Li H: The biological functions and mechanism of miR-212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2. Oncol Rep. 38:1411–1419. 2017. View Article : Google Scholar : PubMed/NCBI

4 

Hu MB, Bai PD, Wu YS, Zhang LM, Xu H, Na R, Jiang HW and Ding Q: Higher body mass index increases the risk for biopsy-mediated detection of prostate cancer in Chinese men. PloS One. 10:e01246682015. View Article : Google Scholar : PubMed/NCBI

5 

Guo L, Min Y, Zhong J, Wu H, Pan J, Gong W, Wang M, Fei F and Hu R: Stroke risk among patients with Type 2 diabetes mellitus in Zhejiang: A population-based prospective study in China. Int J Endocrinol. 2016:63806202016. View Article : Google Scholar : PubMed/NCBI

6 

Karantanos T, Corn PG and Thompson TC: Prostate cancer progression after androgen deprivation therapy: Mechanisms of castrate resistance and novel therapeutic approaches. Oncogene. 32:5501–5511. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Fizazi K, Scher HI, Molina A, Logothetis CJ, Chi KN, Jones RJ, Staffurth JN, North S, Vogelzang NJ, Saad F, et al: Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: Final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study. Lancet Oncol. 13:983–992. 2012. View Article : Google Scholar : PubMed/NCBI

8 

Schrader AJ, Boegemann M, Ohlmann CH, Schnoeller TJ, Krabbe LM, Hajili T, Jentzmik F, Stoeckle M, Schrader M, Herrmann E and Cronauer MV: Enzalutamide in castration-resistant prostate cancer patients progressing after docetaxel and abiraterone. Eur Urol. 65:30–36. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Chi CF, Hu FY, Wang B, Li T and Ding GF: Antioxidant and anticancer peptides from the protein hydrolysate of blood clam (Tegillarca granosa) muscle. J Funct Foods. 15:301–313. 2015. View Article : Google Scholar

10 

Pan X, Zhao YQ, Hu FY, Chi CF and Wang B: Anticancer activity of a hexapeptide from Skate (Raja porosa) cartilage protein hydrolysate in HeLa Cells. Mar Drugs. 14:E1532016. View Article : Google Scholar : PubMed/NCBI

11 

Zhang Z, Gao L, Shen C, Rong M, Yan X and Lai R: A potent anti-thrombosis peptide (vasotab TY) from horsefly salivary glands. Int J Biochem Cell Biol. 54:83–88. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Wang B, Wang YM, Chi CF, Luo HY, Deng SG and Ma JY: Isolation and characterization of collagen and antioxidant collagen peptides from scales of Croceine Croaker (Pseudosciaena crocea). Mar Drugs. 11:4641–4661. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Pan X, Zhao YQ, Hu FY and Wang B: Preparation and identification of antioxidant peptides from protein hydrolysate of skate (Raja porosa) cartilage. J Funct Foods. 25:220–230. 2016. View Article : Google Scholar

14 

Wang X, Xing R, Chen Z, Yu H, Li R and Li P: Effect and mechanism of mackerel (Pneumatophorus japonicus) peptides for anti-fatigue. Food Funct. 5:2113–2119. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Zhao YQ, Zeng L, Yang ZS, Huang FF, Ding GF and Wang B: Anti-fatigue effect by peptide fraction from protein hydrolysate of Croceine Croaker (Pseudosciaena crocea) swim bladder through inhibiting the oxidative reactions including DNA damage. Mar Drugs. 14:2212016. View Article : Google Scholar :

16 

Ovchinnikova TV, Aleshina GM, Balandin SV, Krasnosdembskaya AD, Markelov ML, Frolova EI, Leonova YF, Tagaev AA, Krasnodembsky EG and Kokryakov VN: Purification and primary structure of two isoforms of arenicin, a novel antimicrobial peptide from marine polychaeta Arenicola marina. FEBS Lett. 577:209–214. 2004. View Article : Google Scholar : PubMed/NCBI

17 

Sperstad SV, Haug T, Blencke HM, Styrvold OB, Li C and Stensvåg K: Antimicrobial peptides from marine invertebrates: Challenges and perspectives in marine antimicrobial peptide discovery. Biotechnol Adv. 29:519–530. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Huang F, Yang ZS, Yu D, Wang J, Li R and Ding G: Sepia ink oligopeptide induces apoptosis in prostate cancer cell lines via caspase-3 activation and elevation of Bax/Bcl-2 ratio. Mar Drugs. 10:2153–2165. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Song R, Wei R, Zhang B, Yang Z and Wang D: Antioxidant and antiproliferative activities of heated sterilized pepsin hydrolysate derived from half-fin anchovy (Setipinna taty). Mar Drugs. 9:1142–1156. 2011. View Article : Google Scholar : PubMed/NCBI

20 

Kim EK, Hwang JW, Kim YS, Ahn CB, Jeon YJ, Kweon HJ, Bahk YY, Moon SH, Jeon BT and Park PJ: A novel bioactive peptide derived from enzymatic hydrolysis of Ruditapes philippinarum: Purification and investigation of its free-radical quenching potential. Process Biochem. 48:325–330. 2013. View Article : Google Scholar

21 

Jiang C, Xiong Q, Gan D, Jiao Y, Liu J, Ma L and Zeng X: Antioxidant activity and potential hepatoprotective effect of polysaccharides from Cyclina sinensis. Carbohyd Polym. 91:262–268. 2013. View Article : Google Scholar

22 

Jiang C, Xiong Q, Li S, Zhao X and Zeng X: Structural characterization, sulfation and antitumor activity of a polysaccharide fraction from Cyclina sinensis. Carbohyd Polym. 115:200–206. 2015. View Article : Google Scholar

23 

Jiang C, Wang M, Liu J, Gan D and Zeng X: Extraction, preliminary characterization, antioxidant and anticancer activities in vitro of polysaccharides from Cyclina sinensis. Carbohyd Polym. 84:851–857. 2011. View Article : Google Scholar

24 

Yan HQ, Teng FF, Liu ZX, Huang FF, Yang ZS and Ding GF: Anticancer activity of peptides isolated from hydrolysates of Cylcina sinensis. J Anhui Agri Sci. 42:3576–3577. 2014.

25 

Tang Y, Yu F, Zhang G, Yang Z, Huang F and Ding G: A purified serine protease from Nereis virens and its impaction of apoptosis on human lung cancer cells. Molecules. 22:E11232017. View Article : Google Scholar : PubMed/NCBI

26 

Song R, Wei RB, Luo HY and Yang ZS: Isolation and identification of an antiproliferative peptide derived from heated products of peptic hydrolysates of half-fin anchovy (Setipinna taty). J Funct Foods. 10:104–111. 2014. View Article : Google Scholar

27 

Kim EK, Kim YS, Hwang JW, Lee JS, Moon SH, Jeon BT and Park PJ: Purification and characterization of a novel anticancer peptide derived from Ruditapes philippinarum. Process Biochem. 48:1086–1090. 2013. View Article : Google Scholar

28 

Ibrahim B, Sowemimo A, Spies L, Koekomoer T, Venter MVD and Odukoya OA: Antiproliferative and apoptosis inducing activity of Markhamia tomentosa leaf extract on HeLa cells. J Ethnopharmacol. 149:745–749. 2013. View Article : Google Scholar : PubMed/NCBI

29 

Deng X, Qiu Q, Yang B, Wang X, Huang W and Qian H: Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities. Eur J Med Chem. 89:540–548. 2015. View Article : Google Scholar : PubMed/NCBI

30 

Ma J, Huang F, Lin H and Wang X: Isolation and purification of a peptide from Bullacta exarata and its impaction of apoptosis on prostate cancer cell. Mar Drugs. 11:266–273. 2013. View Article : Google Scholar : PubMed/NCBI

31 

Yang Z, Zhao Y, Yan H, Xu L, Ding G, Yu D and Sun Y: Isolation and purification of oligopeptides from Ruditapes philippinarum and its inhibition on the growth of DU-145 cells in vitro. Mol Med Rep. 11:1063–1068. 2015. View Article : Google Scholar : PubMed/NCBI

32 

Kuwana T and Newmeyer DD: Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr Opin Cell Biol. 15:691–699. 2003. View Article : Google Scholar : PubMed/NCBI

33 

Mcilwain DR, Berger T and Mak TW: Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol. 5:a0086562013. View Article : Google Scholar : PubMed/NCBI

34 

Kumar S: Caspase function in programmed cell death. Cell Death Differ. 14:32–43. 2007. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yu F, Zhang Y, Ye L, Tang Y, Ding G, Zhang X and Yang Z: A novel anti‑proliferative pentapeptide (ILYMP) isolated from Cyclina sinensis protein hydrolysate induces apoptosis of DU‑145 prostate cancer cells. Mol Med Rep 18: 771-778, 2018.
APA
Yu, F., Zhang, Y., Ye, L., Tang, Y., Ding, G., Zhang, X., & Yang, Z. (2018). A novel anti‑proliferative pentapeptide (ILYMP) isolated from Cyclina sinensis protein hydrolysate induces apoptosis of DU‑145 prostate cancer cells. Molecular Medicine Reports, 18, 771-778. https://doi.org/10.3892/mmr.2018.9019
MLA
Yu, F., Zhang, Y., Ye, L., Tang, Y., Ding, G., Zhang, X., Yang, Z."A novel anti‑proliferative pentapeptide (ILYMP) isolated from Cyclina sinensis protein hydrolysate induces apoptosis of DU‑145 prostate cancer cells". Molecular Medicine Reports 18.1 (2018): 771-778.
Chicago
Yu, F., Zhang, Y., Ye, L., Tang, Y., Ding, G., Zhang, X., Yang, Z."A novel anti‑proliferative pentapeptide (ILYMP) isolated from Cyclina sinensis protein hydrolysate induces apoptosis of DU‑145 prostate cancer cells". Molecular Medicine Reports 18, no. 1 (2018): 771-778. https://doi.org/10.3892/mmr.2018.9019
Copy and paste a formatted citation
x
Spandidos Publications style
Yu F, Zhang Y, Ye L, Tang Y, Ding G, Zhang X and Yang Z: A novel anti‑proliferative pentapeptide (ILYMP) isolated from Cyclina sinensis protein hydrolysate induces apoptosis of DU‑145 prostate cancer cells. Mol Med Rep 18: 771-778, 2018.
APA
Yu, F., Zhang, Y., Ye, L., Tang, Y., Ding, G., Zhang, X., & Yang, Z. (2018). A novel anti‑proliferative pentapeptide (ILYMP) isolated from Cyclina sinensis protein hydrolysate induces apoptosis of DU‑145 prostate cancer cells. Molecular Medicine Reports, 18, 771-778. https://doi.org/10.3892/mmr.2018.9019
MLA
Yu, F., Zhang, Y., Ye, L., Tang, Y., Ding, G., Zhang, X., Yang, Z."A novel anti‑proliferative pentapeptide (ILYMP) isolated from Cyclina sinensis protein hydrolysate induces apoptosis of DU‑145 prostate cancer cells". Molecular Medicine Reports 18.1 (2018): 771-778.
Chicago
Yu, F., Zhang, Y., Ye, L., Tang, Y., Ding, G., Zhang, X., Yang, Z."A novel anti‑proliferative pentapeptide (ILYMP) isolated from Cyclina sinensis protein hydrolysate induces apoptosis of DU‑145 prostate cancer cells". Molecular Medicine Reports 18, no. 1 (2018): 771-778. https://doi.org/10.3892/mmr.2018.9019
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team